App and website aim to ease perinatal depression care
NCT ID NCT05525689
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a technology service to help care managers in obstetrics clinics treat depression during pregnancy and after birth. 75 women with moderate to severe depression used an app for symptom tracking and a website with educational content. The goal was to see if these tools improve depression and anxiety outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IntelliCare app and COMPASS-Care website
- What this could lead to
- If successful, this could show that technology tools help care managers better treat depression during and after pregnancy.
- What could go wrong
- This is a small, completed study with 75 participants, so results may not apply to everyone. It tested a service, not a new drug, so the impact is limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prentice Women's Hospital
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers